Accepted Article

DR DUYGU AYHAN BASER (Orcid ID : 0000-0002-5153-2184)

DR HILAL AKSOY (Orcid ID : 0000-0002-3330-9317)

DR İZZET FIDANCI (Orcid ID : 0000-0001-9848-8697)

Article type : Original Paper

WHILE STUDIES ON COVID-19 VACCINE IS ONGOİNG; THE PUBLIC’S THOUGHTS

AND ATTITUDES TO THE FUTURE COVID-19 VACCINE

ABSTRACT

OBJECTİVE

In this study, we aim to investigate the thoughts and attitudes of individuals towards the future
COVID-19 vaccine.

METHODS

This descriptive study was carried out on the web between 10/06/2020 - 10/07/2020. The sample
constitutes all individuals above 18 years of age using social media and smartphone. The e-survey
form was shared by the researchers via the web for a month, and those who completed the survey
were included in the study and formed the sample of the research.

RESULTS

Seven hundred fifty-nine were participated. 49.7% of the participants stated to be vaccinated;
38.4% of them stated to be vaccinated their children against COVID-19; if the vaccine for
COVID-19 is developed. The request for the COVID-19 vaccine had relationship with gender,
occupation, health insurance, anxiety level, having children, willing to get vaccinated for their
children. “Afraid of the side effects of vaccine”, “don’t think it can be reliable as it will be a new

This article has been accepted for publication and undergone full peer review but has not been
through the copyediting, typesetting, pagination and proofreading process, which may lead to
differences between this version and the Version of Record. Please cite this article as doi:
10.1111/ijcp.13891
This article is protected by copyright. All rights reserved
 vaccine” and “COVID-19 infection is a biological weapon and the vaccine will serve those who
Accepted Article
produce this virus” were the most common reasons for rejection of vaccine.

CONCLUSION

In our study afraid of the side effects of vaccine and not thinking it can be reliable as it will be a
new vaccine is the most reasons of indecision and rejection about COVID 19 vaccine. In order for
the future COVID 19 vaccination campaign to not fail, media, politicians, healthcare professionals
should closely follow the vaccination development processes, inform the public transparently and
consider public’s concerns.

KEYWORDS: COVID-19, SARS-CoV-2, Vaccine, Vaccination, Community, Thoughts,

Attitudes, Public, Primary care

What’s already known about this topic?

Vaccination researches for SARS-CoV-2 are also ongoing in the large centers. The vaccines are
known to be effective in creating a long-lasting immune memory to control infectious diseases.
Vaccines currently prevent 2-3 million deaths per year. There is an urgent and important need to
manufacture and distribute enough safe and effective vaccine to immunize individuals in order to
protect the entire global community from the threat of morbidity and mortality from SARS-CoV-
2.

What does this article add?

Forty nine point seven percent of the participants stated that if the vaccine for COVID-19 infection
is developed, they will be vaccinated against COVID-19. The most important reason for
willingness to be vaccinated is to be thinking that vaccination will be important not only for
him/herself or his/her children but also for protecting the health of people around him/her or
his/her children. This shows that people are aware that vaccines provide not only individual but
also social protection. Five point eight percent of the participants stated that they will be
vaccinated if the vaccine is free. Economic reasons are important too, also our study support this
issue.

This article is protected by copyright. All rights reserved

Accepted Article

WHILE STUDIES ON COVID-19 VACCINE IS ONGOİNG; THE PUBLIC’S THOUGHTS

AND ATTITUDES TO THE FUTURE COVID-19 VACCINE

INTRODUCTION

The COVID-19 infection, which the World Health Organization has declared as a “pandemic”
because it has spread to more than 114 countries, has caused more than 43.140.173 confirmed
cases and more than 1.155.235 deaths as of 25 October 2020 (1-3).

Developing drugs for SARS COV-2 is an important issue for the scientists and currently there is
no officially approved drugs to treat COVID-19 infection (1-3). In addition to the clinical research
of old and new drugs, vaccination researches for SARS-CoV-2 are also ongoing in the large
centers (4-5). The vaccines are known to be effective in creating a long-lasting immune memory to
control infectious diseases. Vaccines currently prevent 2-3 million deaths per year (4). Various
vaccines have been developed in pandemics such as the 1957, 1968, 1976, 1977 outbreaks and the
H5N1 outbreak (1997-1998), and the 2009 H1N1 outbreak (5). In the studies conducted in the

This article is protected by copyright. All rights reserved

 H1N1 pandemic, it has been stated that the senior citizens, men, those from an ethnic minority and
Accepted Article
those who are doctors among healthcare workers are more moderate and willing to vaccinate (6).

It is believed that with the availability of a safe and effective vaccine for COVID-19, a great
progress will be made in controlling the pandemic. On April 2, 2020 “ Vaccine and Drug
Development virtual conference" was held with coordination of Turkish COVID-19 platform in
Turkey. In the opening speech of the conference, Turkey’s Minister of Industry and Technology
said, "Under the COVID-19 Platform, there are seven different vaccine development projects and
seven different drug development projects that both chemical and biotechnological methods will
be applied"(7). More than a hundred companies or academic institutions around the world are
working on COVID-19 vaccines with strategies that include recombinant vectors, mRNA, DNA,
inactivated virus, live attenuated virus, virus-like particles, and protein subunits in lipid
nanoparticles (8). As of 19 October 2020, there are 44 candidate vaccines in the clinical evaluation
(9).

While studies on COVID-19 vaccine is ongoing, the vaccine hesitancy or refusal for vaccine-
preventable disease reverses the progress made in the fight for these diseases. Therefore, it is of
great importance to evaluate the perspective of the society in this regard. In this study, we aim to
investigate the thoughts and attitudes of individuals towards the future COVID-19 vaccine.

METHODS

This descriptive study was carried out on the web between 10/06/2020 - 10/07/2020. The research
population constitutes all individuals above 18 years of age using social media and smartphone in
Turkey. The e-survey form was shared by the researchers, and those who completed the survey
were included in the study and formed the sample of the research. The survey form was shared on
whatsapp, facebook and instagram. The target number of people was reached by the snowball
method. Sampling calculation has not been made and people answered the questionnaire within
the specified period were included in the study. It is aimed to reach at least 500 adults.

The questionnaire to be used in the research was prepared by the researchers, there are 24
questions in total. The questionnaire contains 7 questions for sociodemographic characteristics
(gender, age, occupation etc.) and 2 questions for health conditions. There are 3 questions about
COVID-19 infection, 12 questions about participants' opinions about vaccines and future COVID-
19 vaccine. Participants were asked to rate their anxiety levels against COVID-19 between 0-10.

This article is protected by copyright. All rights reserved

 After the approval of the ethics committee, data was collected via the web for one month. The e-
Accepted Article
survey form developed by the researchers was shared 10 times in three days’ intervals on the web.
Voluntary consent form was added to the questionnaire, participants who responded positively to
the voluntary consent form completed the questionnaire. The people who answered all the
questions were included in the study.

Data Analysis

Mean ± standard deviation for the variables that were continuous from the demographic
information of the participants, and frequency tables for the qualitative data was created. The
consistency of continuous variables to normal distribution was examined using visual (histogram
and possible graphics) and analytical methods (Kolmogorov-Smirnov / Shapiro-Wilk). Correlation
coefficients and statistical significance were calculated by Pearson test when both variables were
normally distributed in correlation analyzes, or by Spearman test for at least one normal
distribution or ordinal variables. Chi-Square test was used to investigate the relationships between
qualitative data. Differences between group values of continuous variables were investigated with
t test, ANOVA test or tests with their nonparametric equivalents. The value of α = 0.05 was
chosen as the level of error and probability values obtained from statistical analysis were
interpreted accordingly. Statistical analysis was done with SPSS 23 package program.

Permission and approval of the ethics committee

The study was conducted in accordance with the principles of the Helsinki Declaration related to
conducting clinical trials on humans, and the research proposal was approved by the Ethics
Committee of the XXX University with the number of GO 20/556 at June 2020.

RESULTS

Seven hundred fifty-nine participants were participated. The mean age of the participants is 32.41
± 9.92 (min = 18; max = 81) and 62.8% were female. Detailed sociodemographic characteristics of
participants were at Table 1.

Table 1. Sociodemographic Characteristics of Participants

This article is protected by copyright. All rights reserved

 Forty nine point seven percent of the participants stated that if the vaccine for COVID-19 infection
Accepted Article
is developed, they will be vaccinated against COVID-19. Vaccination requests of participants
against COVID-19 were at Graphic 1.

35.9
49.7

8.6
5.8

YES, I WILL BE VACCINATED YES IF IT'S FREE NO, I DONT UNDECIDED

Graphic 1. Vaccination requests of participants against COVID-19

Of the participants 0.8% (n = 6) had COVID-19 infections, 17.1% (n = 130) of their relatives had
COVID-19 infections. The average level of anxiety for COVID 19 infection was 6.04 ± 2.30 (min
= 0; max = 10). COVID-19 infection measure practices of the participants are presented in Table
2.

Table 2. COVID 19 infection measure practices of the participants

Thirty point six percent (n = 232) of participants had children between the ages of 0-18, 6.2% (n =
14) of those rejected any of the vaccines within the National Vaccination Program for their
children and 58.5% (n = 134) of them were getting their children vaccines which were not at
National Vaccination Program and had paid (meningococcal vaccine, influenza vaccine, HPV
vaccine, etc.). Of the participants 38.4% stated that if the vaccine for COVID-19 infection is
developed, they will be vaccinated their children against COVID-19. Vaccination requests of
participants for their children against COVID-19 were at Graphic 2.

This article is protected by copyright. All rights reserved

Accepted Article
38.4
43.2

14.8
3.5

YES, I WİLL BE VACCINATED YES IF IT'S FREE NO, I DONT UNDECIDED

Graphic 2. Vaccination requests of participants for their children against COVID-19

The relationship of some factors and vaccination requests of participants for themselves and for
their children against COVID-19 are presented at Table 3. It was seen that women had more
negative opinions (don't get vaccinated/ undecided) about getting vaccinated than men (p=0.001).
While students and health professionals were more willing to vaccinate, those who did not work
stated that they were more undecided than other occupational groups (p=0.026). Those who have
SSI or private health insurance (p=0.004), who got seasonal flu vaccine (p<0.001), who had
children (p=0.048) and those who were thinking about getting their child COVID-19 vaccine
(p<0.001) stated that they were more willing to get vaccinated than others. As the level of anxiety
increases, the willingness to get vaccinated increases (p=0.010). With the increasing level of
education, the participants' thoughts about getting vaccinated for their children was increased
(p<0.001). Those who have SSI or private health insurance (p=0.006), who got seasonal flu
vaccine (p=0.023) stated that they were more willing to get vaccinated than others.

Table 3. The relationship of some factors and vaccination requests of participants for
themselves and for their children against COVID-19

“Afraid of the side effects of vaccine”, “don’t think it can be reliable as it will be a new vaccine”
and “COVID-19 infection is a biological weapon and the vaccine will serve those who produce
this virus” were the most common reasons for rejection of vaccine both for themselves and for
their children. The reasons of undecision and rejection about COVID-19 vaccine is presented at
Table 4.

Table 4. The reasons of undecision and rejection about COVID-19 vaccine

This article is protected by copyright. All rights reserved

 “Vaccination will be important to protect against COVID-19 disease” and “vaccination will be
Accepted Article
important not only for myself/my children but also for protecting the health of people around
me/my children” were the most common reasons for request of vaccine both for themselves and
for their children. The reasons of request for COVID-19 vaccine is presented at Table 5.

Table 5. The reasons of request for COVID-19 vaccine

DISCUSSION
The current estimated mortality rate of SARS-CoV-2 is around 6.9% but varies among different
countries (10). There is an urgent and important need to manufacture and distribute enough safe
and effective vaccine to immunize individuals in order to protect the entire global community
from the threat of morbidity and mortality from SARS-CoV-2 (11). Also in our study 49.7% of the
participants stated that if the vaccine for COVID-19 infection is developed, they will be
vaccinated against COVID-19. The most important reason for willingness to be vaccinated is to be
thinking that vaccination will be important not only for him/herself or his/her children but also for
protecting the health of people around him/her or his/her children. This shows that people are
aware that vaccines provide not only individual but also social protection. The second reason for
being vaccinated is to be thinking that vaccination will be important to protect against COVID-19
disease.
However, there is not any vaccine currently licensed for any of the other coronaviruses affecting
humans. These are; SARS-CoV-1, MERS-CoV, and minor cold viruses. Economic reasons are of
course a major factor for the absence of these vaccines. But despite economic challenges, vaccine
design is also a challenge. Immune responses to natural coronavirus infections can be short lived,
and some trial vaccines for SARS-CoV-1 raised safety concerns in animal models (12).
In our study we investigated the thoughts and attitudes of individuals towards the future COVID-
19 vaccine. Eight point six percent of the participants stated that if the vaccine for COVID-19
infection is developed, they will not be vaccinated against COVID-19 and 35.9% of them are
undecided. Fourteen point eight percent of the participants stated that if the vaccine for COVID-19
infection is developed, they will not be vaccinated their children against COVID-19 and 43.2% of
the patents are undecided. In addition, people who had children and who were thinking about
getting COVID-19 vaccine to their children were more willing to get vaccinated than others. With
the increasing level of education, the participants' thoughts about getting vaccinated for their
children was increased. People are more reluctant to vaccinate their children than their own

This article is protected by copyright. All rights reserved

 vaccination. This may be due to different reasons related to vaccines and immunization policies,
Accepted Article
which are being discussed and questioned with increasing momentum.
The current pandemic entails three important challenges for public confidence in and uptake of a
future, licensed vaccine. First, evidence shows that if the vaccine is new, the level of hesitancy
will be high (13). Second, one reason; people trust vaccines is the slow and methodical process it
takes to develop them, which may take up to several years before final approval. While evidence-
based medicine is essential, the marketing-based pharmaceutical industry is the reality of our time.
Pharmaceutical companies have captured science to make more profit (14). A third challenge
relates to misinformation by anti-vaccination campaigners. Vaccines are also one of the topics that
are increasingly being questioned and discussed.
Recent studies have shown that COVID-19 vaccine hesitancy level varies from low to high, with
some 29% of New York residents claiming they will refuse a vaccine, compared to 20% of those
in Canada and 6% of those in the UK (15,16). We currently know little about what constitutes a
protective immune response against COVID-19.
In our study afraid of the side effects of vaccine and not thinking it can be reliable as it will be a
new vaccine is the most reasons of indecision and rejection about COVID-19 vaccine for
themselves and for their children. There are many studies in the scientific literature on the content
and side effects of the vaccines (17-21). There are also publications in the literature about the
autoimmune diseases reported after the vaccinations (22).

In our study 5.8% of the participants stated that they will be vaccinated if the vaccine is free.
Economic reasons are important too, also our study support this issue; not working people were
more undecided and those who have social insurance (SSI) or private health insurance were more
willing to get vaccinated. Studies in the literature, lower price barrier and higher ability to pay
were associated with higher willingness to pay (23-24). But the decision to add a new vaccine to
the national immunization program requires a very extensive and comprehensive assessment.
Decision making process also influenced by social values, perceptions and political approaches
(25).
Another important result in our study was that, participants who got seasonal flu vaccine were
more willing to get vaccinated and also to get vaccinated their children against COVID-19 than
others. Seasonal flu vaccine is salaried in Turkey. Also people could have paid for seasonal flu

This article is protected by copyright. All rights reserved

 vaccine and those who care about vaccination were more willingness for vaccination against
Accepted Article
COVID-19.
Heath anxiety occurs when perceived bodily sensations or changes, are interpreted as symptoms of
being ill and play a vital role in the success of public health strategies used to manage epidemics
and pandemics; that is, risk communication, vaccination and antiviral therapy, hygiene practices,
and social distancing (26). As the level of anxiety increases, the willingness to get vaccinated
increases in our study. In accordance with our study, anxiety level and vaccine history were the
main affecting factors for the willingness of future A/H7N9 influenza vaccine uptake (27).
Health professionals were more willing to vaccinate in our study. During 2009 H1N1 Pandemic,
because of the high risk perception of healthcare workers, vaccination rates have increased (28-
31). In one study from Italy (n = 2557) vaccination in pandemics 17% while, vaccination rate
decreased to 7.8% in 2012-2013 season after pandemic (32).
Limitations included the methodological limitation of web based survey. For our sample
population, they had higher education level, higher rates of health care professional and cannot be
generalized to society.
CONCLUSION
Health professionals should act with a sense of responsibility in the
recommendations on immunization policies and vaccinations and should know that
each vaccine has different characteristics (content, side effects, efficacy, safety,
importance and necessity). Recommendations from peers and healthcare providers increase
willingness to vaccination (24). Adverse effects on people's confidence in healthcare
professionals should be taken into account when recommending or rejecting
vaccinations. In order for the future COVID-19 vaccination campaign to not fail, media,
politicians, healthcare professionals should closely follow the vaccination development processes,
inform the public transparently and consider public’s concerns.
Compliance with Ethical Standards

Disclosure of potential conflicts of interest

The authors declared no conflict of interest concerning the research, authorship, or publication of
this article.

Research involving Human Participants and/or Animals

This article is protected by copyright. All rights reserved

 This research involved human participants’ data and authors include a statement that confirms that
Accepted Article
the study was approved by Hacettepe University research ethics committee and certify that the
study was performed in accordance with the ethical standards as laid down in the 1964 Declaration
of Helsinki.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Data Availability Statement

The Authors declare that materials described in the manuscript, including all relevant raw data,
will be freely available to any scientist wishing to use them for non-commercial purposes, without
breaching participant confidentiality. Moreover, the Authors ensure that their datasets are
presented in the main manuscript.

REFERENCES

1. T. C. Ministry of Health General Directorate of Public Health 2020. COVID-19 (SARS-

CoV2 Infection) Guideline. https://covid19bilgi.saglik.gov.tr/tr/covid-19-rehberi.html
(Date of access:27.07.2020)
2. Xu K, Cai H, Shen Y, et al. The Zhejiang experience 2020. Zhejiang Da Xue Xue Bao Yi
Xue Ban 2020;49(1):0. PMID: 32096367
3. WHO Coronavirus Disease (COVID-19) Dashboard.
https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (Date of access:
27.07.2020)
4. WHO Coronavirus disease (COVID-19) pandemic. https://www.who.int/news-
room/feature-stories/ten-threats-to-global-health-in-2019 (Date of access: 27.07.2020)
5. Wood JM. Developing vaccines against pandemic influenza. Philos Trans R Soc Lond B
Biol Sci 2001; 356 (1416): 1951-60.
6. Bish A, Yardley L, Nicoll C, Michie S. Factors associated with uptake of vaccination
against pandemic influenza: A systematic review. Vaccine 2011; 29 (38): 6472-6484.

This article is protected by copyright. All rights reserved

 7. T.
Accepted Article C. Ministry of Health General Directorate of Public Health 2020.
https://covid19.tubitak.gov.tr/duyurular/covid-19-turkiye-platformu-asi-ve-ilac-
gelistirme-sanal-konferansi-duzenledi. (Date of access: 27.07.2020)
8. Thanh Le T, Andreadakis Z, Kumar A, Gomez Roman R, Tollefsen S, Saville M,
Mayhew S. The COVID-19 vaccine development landscape. Nat Rev Drug Discov 2020;
19: 305-306.
9. WHO Coronavirus Disease (COVID-19) Dashboard. https://www.who.int/who-
documents-detail/draft-landscape-of-covid-19-candidate-vaccines. (Date of access:
27.07.2020)
10. Guan WJ, Ni ZY, Hu Y et al. Clinical characteristics of coronavirus disease 2019 in
China. N. Engl. J. Med 2020; 382: 1708– 1720
11. Corey L, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine
R&D. Science 2020; 368(6494): 948-950. DOI: 10.1126/science.abc5312
12. Amanat F, Krammer F. SARS-CoV-2 vaccines: status report. Immunity 2020; 52: 583-
589. doi:10.1016/j.immuni.2020.03.007 PMID:32259480
13. Dubé E, Laberge C, Guay M, et al. Vaccine hesitancy: an overview. Hum Vaccines
Immunother. 2013;9(8):1763–1773. doi: 10.4161/hv.24657
14. Spielmans GI, Parry PI. From Evidence-based Medicine to Marketing-based
Medicine: Evidence from Internal Industry Documents. J Bioeth Inq 2010; 7
(1):13-29. doi:10.1007/s11673-010-9208-8
15. Latimer K. About 20% of people in recent survey said they wouldn’t take COVID-19
vaccine 2020; https://www.cbc.ca/news/canada/saskatchewan/covid-survey-first-round-
results-1.5541053. . (Date of access: 27.07.2020)
16. Henley J and Guardian correspondents (2020) Coronavirus causing some anti-vaxxers to
waver, experts say. https://www.theguardian.com/world/2020/apr/21/anti-vaccination-
community-divided-how-respond-to-coronavirus-pandemic. (Date of access: 27.07.2020)
17. Ball LK, Ball R, Pratt RD. An assessment of thimerosal use in childhood vaccines.
Pediatrics 2001;107 (5):1147-1154. doi:10.1542/peds.107.5.1147.
18.Drasch G, Aigner S, Roider G, Staiger E, Lipowsky G. Mercury in human colostrum
and early breast milk, its dependence on dental amalgam and other factors. J Trace Elem
Med Biol 1998;12(1):23-27. doi:https://doi.org/10.1016/S0946-672X (98)80017-5.

This article is protected by copyright. All rights reserved

Accepted Article 19.Bose-O’Reilly S, Mccarty K, Steckling N, Lettmeier B. Mercury exposure and
children’s health. Curr Probl Pediatr Adolesc Health Care 2010; 40: 186-
215.doi:10.1016/j.cppeds.2010.07.002.
20.Hessel L. Mercury in vaccines. Bull Acad Natl Med 2003;187(8):1501-1510.
http://www.ncbi.nlm.nih.gov/pubmed/15146581.
21.Shaw C, Tomljenovic L. Aluminum in the central nervous system (CNS): Toxicity in
humans and animals, vaccine adjuvants, and autoimmunity. Immunol Res 2013;56 (2-
3):304-316. doi:10.1007/s12026-013-8403-1
22. Orbach H, Agmon-Levin N, Zandman-Goddard G. Vaccines and autoimmune diseases
of the adult. Discov Med 2010;9 (45):90-97.
23. Zhiyuan Hou, Jie Chang, Dahai Yue, Hai Fang, Qingyue Meng, Yuting Zhang.
Determinants of willingness to pay for self-paid vaccines in China, Vaccine 2014, 32(35),
4471-4477, doi.org/10.1016/j.vaccine.2014.06.047.
24.Bish AL, Yardley A, Nicoll S, Michie S. Factors associated with uptake of vaccination
against pandemic influenza: a systematic review Vaccine 2011; 29 (38): 6472-6484
25. Kartal M, Güldal D. Yeni Aşıların Ulusal Programda Yer Alma Süreci. Türkiye
Klin J Fam Med-Special To. 2011;2 (5):5-10.
26. Asmundson GJG, Taylor S. How health anxiety influences responses to viral outbreaks
like COVID-19: What all decision-makers, health authorities, and health care professionals
need to know. J Anxiety Disord. 2020;71:102211. doi:10.1016/j.janxdis.2020.102211
27. Emily Ying-Yang Chan, Calvin Ka-Yeung Cheng, Greta Chun-Huen Tam, Zhe Huang,
Po Yi Lee, Willingness of future A/H7N9 influenza vaccine uptake: A cross-sectional
study of Hong Kong community, Vaccine 2015, 33 (38); 4737-4740,
doi.org/10.1016/j.vaccine.2015.07.046.). PMCID: PMC7271220
28. Gürbüz Y, Tütüncü EE, Şencan İ, et al. İnfluenza A (H1N1) 2009 pandemisinde
hastane çalışanlarının grip aşısına yaklaşımlarının araştırılması. Pamukkale Tıp Dergisi
2013; 6(1): 12–7. 10.
29.Sevencan F, Ertem M, Özçullu N, Dorman V, Kubat NK. The evaluation of the
opinions and attitudes of healthcare personnel of the province Diyarbakir against influenza
A (H1N1) and the vaccination. Hum Vaccin 2011; 7(9): 945-51.

This article is protected by copyright. All rights reserved

Accepted Article 30. Örmen B, Türker N, Vardar İ, et al. Hastane personeline pandemik influenza A (H1N1)
aşı uygulamasının ardından aşılama hakkındaki görüşler ve gözlenen yan etkiler.
Mikrobiyol Bül 2012; 46(1): 57-64.
31.Arda B, Durusoy R, Yamazhan T et al. Did the pandemic have an impact on influenza
vaccination attitude? A survey among health care workers. BMC Infect Dis. 2011; 11: 87.
32.Giannattasio A, Mariano M, Romano R, et al. Sustained low influenza vaccination in
health care workers after H1N1 pandemic: a cross sectional study in an Italian health care
setting for at-risk patients. BMC Infect Dis. 2015; 15: 329.

This article is protected by copyright. All rights reserved

Accepted Article
Table 1. Sociodemographic Characteristics of Participants

TOTAL
Number (n) Percentage (%)

Gender:
Female 477 62.8
Male 282 37.2
Educational status:
Not Literate 2 0.3
Literate 3 0.4
Primary school 21 2.8
High school 83 10.9
University 483 63.6
Master / PhD 167 22
Marital Status
Married 354 46.6
Single 405 53.4
Profession
Not working 96 12.6
Student 104 13.7
Health employee 308 40.6

This article is protected by copyright. All rights reserved

Accepted Article
Other 251 33.1

Monthly income
<1000 103 13.6
1000-2000 71 9.4
2000-3000 82 10.8
3000-4000 72 9.5
> 4000 431 56.8
Health insurance type
SSI 623 82.1
Special 49 6.5
Other 50 6.6
Family type
Nuclear family 690 90.9
Extended family 69 9.1
Chronic disease state
Yes 139 18.3
No 620 81.7

Table 2. COVID 19 infection measure practices of the participants

TOTAL

This article is protected by copyright. All rights reserved

Accepted Article
Number (n) Percent (%)
Using a mask 745 98.2
Washing hands 723 95.3
Taking care not to touch eyes, mouth and nose with 645 85
hands.
Avoiding to go out, going into crowded places 609 80.2
Ventilation of environment at work, at home 559 73.6
Avoiding to close contact with people such as 684 90.1
handshaking, hugging, keep a distance of 1.5
meters
İmproving to diet and sleep, started to consume 209 27.5
healthy foods and drink more water.
None of them 1 0.1

Table 3. The relationship of some factors and vaccination requests of participants against COVID 19

VACCINATION REQUEST AGAINST COVID 19 VACCINATION REQUEST FOR THEIR CHILDREN

AGAINST COVID 19
Yes, get If it is free, No, don't Undecided p Yes, get If it is free, No, don't Undecided p
vaccinated get it done get vaccinated get it done get
vaccinated vaccinated

This article is protected by copyright. All rights reserved

Accepted Article
n % n % n % n % n % n % n % n %
Age:
<25 105 27.9 14 31.8 13 20 69 25.2 1 1.1 0 0 2 5.9 1 1
26-30 125 33.2 14 31.8 13 20 84 30.8 0.78 13 14.8 0 0 5 14.7 12 12.1 0.58
31-35 42 11.1 3 6.8 17 26.2 43 15.8 20 22.7 2 25 10 29.4 35 35.4
36-40 30 8 6 13.6 8 12.3 22 8.1 19 21.6 3 37.5 7 20.6 21 21.2
>40 75 19.9 7 15.9 14 21.5 55 20.1 35 39.8 3 37.5 10 29.4 30 30.3
Gender:
Female 214 56.8 24 54.5 47 72.3 192 70.3 0.001 47 53.4 3 37.5 21 61.8 67 67.7 0.12
Male 163 43.2 20 45.5 18 27.7 81 28.7 41 46.6 5 62.5 13 38.2 32 32.3
Educational
status:
Not Literate 0 0 0 0 1 1.5 1 0.4 0 0 1 12.5 0 0 0 0
Literate 2 0.5 0 0 0 0 1 0.4 1 1.1 0 0 0 0 0 0
Primary 14 3.7 1 2.3 0 0 6 2.2 0.26 7 8 1 12.5 0 0 2 2 <0.001
school
High school 32 8.5 7 15.9 11 16.9 33 12.1 15 17 0 0 9 26.5 19 19.2
University 240 63.7 31 70.5 40 61.5 172 63 47 53.4 6 75.0 19 55.9 58 58.6
Master / 89 23.6 5 11.4 13 20 60 22 18 20.5 0 0 6 17.6 20 20.2
PhD
Marital
Status
Married 160 42.4 19 43.2 36 55.4 139 50.9 0.07 84 95.5 8 100 30 88.2 95 96 0.29

This article is protected by copyright. All rights reserved

Accepted Article
Single 217 57.6 25 56.8 29 44.6 134 49.1 4 4.5 0 0 4 11.8 4 4
Profession
Not working 38 10.1 8 18.2 9 13.8 41 15 14 15.9 1 12.5 7 20.6 15 15.2
Student 63 16.7 8 18.2 5 7.7 28 10.3 0.026 0 0 0 0 1 2.9 0 0 0.42
Health 167 44.3 14 31.8 26 40.0 101 37.0 34 38.6 2 25 11 32.4 29 29.3
employee
Other 109 28.9 14 31.8 25 38.5 103 37.7 40 45.5 5 62.5 15 44.1 55 55.6
Monthly
income
<1000 46 12.2 10 22.7 7 10.8 40 14.7 2 2.3 0 0 0 0 2 2
1000-2000 40 10.6 4 9.1 3 4.6 24 8.8 0.o9 7 8 1 12.5 2 5.9 8 8.1 0.43
2000-3000 38 10.1 4 9.1 8 12.3 32 11.7 17 19.3 0 0 6 17.6 14 14.1
3000-4000 23 6.1 5 11.4 9 13.8 35 12.8 8 9.1 1 12.5 10 29.4 13 13.1
> 4000 230 61 21 47.7 38 58.5 142 52 54 61.4 6 75 16 47.1 62 62.6
Health
insurance
type
SSI 323 85.7 30 68.2 50 76.9 220 80.6 0.004 78 88.6 4 50 25 73.5 80 80.8 0.006
Special 26 6.9 3 6.8 2 3.1 18 6.6 5 5.7 1 12.5 1 2.9 7 7.1
Other 15 4 6 13.6 10 15.4 19 7 1 1.1 3 37.5 4 11.8 9 9.1
Family type
Nuclear
family 343 91 38 86.4 60 92.3 249 91.2 0.73 76 86.4 5 62.5 28 82.4 91 91.9 0.06

This article is protected by copyright. All rights reserved

Accepted Article
Extended
family 34 9 6 13.6 5 7.7 24 8.8 12 13.6 3 37.5 6 17.6 8 8.1
Chronic
disease state
Yes 67 17.8 6 13.6 11 16.9 55 20.1 0.70 21 23.9 1 12.5 8 23.5 21 21.2 0.88
No 310 82.2 38 86.4 54 83.1 218 79.9 67 76.1 7 87.5 26 76.5 178 78.8
Vaccination
against
Seasonal
Flu in the <0.001 0.023
Last 1 Year
Yes 54 14.3 5 11.4 2 3.1 14 5.1 14 15.9 1 12.5 0 0 6 6.1
No 323 85.7 39 88.6 63 96.9 259 94.9 74 84.1 7 87.5 34 100 93 93.9
Infection
Status with
COVID-19
Yes 3 0.8 1 2.3 1 1.5 1 0.4 0.50 0 0 1 12.5 0 0 1 1.0 0.004
No 374 99.2 43 97.7 64 98.5 272 99.6 88 100.0 7 87.5 34 100 98 99.0
Infection
Status of
relatives
with 0.46
COVID-19 0.33

This article is protected by copyright. All rights reserved

Accepted Article
Evet 74 19.6 6 13.6 9 13.8 41 15 15 17 2 25 3 8.8 12 12.1
Hayır 303 80.4 38 86.4 56 86.2 232 85 73 83 6 75 31 91.2 87 87.9
Anxiety
Level for
COVID-19
Infection
0 0 0 0 0 0 0 3 1.1 0 0 0 0 0 0 1 1
1 13 3.4 6 13.6 6 9.2 12 4.4 6 6.8 1 12.5 4 11.8 2 2
2 7 1.9 2 4.5 2 3.1 11 4 0.010 1 1.1 0 0 1 2.9 4 4 0.23
3 24 6.4 2 4.5 5 7.7 18 6.6 1 1.1 1 12.5 3 8.8 8 8.1
4 21 5.6 0 0 5 7.7 18 6.6 4 4.5 0 0 3 8.8 6 6.1
5 71 18.8 10 22.7 23 35.4 48 17.6 21 23.9 2 25 7 20.6 21 21.2
6 60 15.9 6 13.6 5 7.7 35 12.8 5 5.7 1 12.5 6 17.6 6 6.1
7 66 17.5 5 11.4 7 10.8 66 24.2 11 12.5 2 25 3 8.8 23 23.2
8 54 14.3 8 18.2 6 9.2 30 11 20 22.7 1 12.5 2 5.9 11 11.1
9 27 7.2 3 6.8 2 3.1 12 4.4 7 8 0 0 2 5.9 4 4
10 34 9 2 4.5 4 6.2 20 7.3 12 13.6 0 0 3 8.8 13 13.1

The
condition of
having paid
vaccinations
for the child

This article is protected by copyright. All rights reserved

Accepted Article
Yes 68 68.7 5 41.7 11 45.8 50 53.2 0.07 61 69.3 3 37.5 16 47.1 53 54.1 0.07
No 29 29.3 7 58.3 12 50 37 39.4 25 28.4 5 62.5 17 50 38 38.8
I have no 2 2 0 0 1 4.2 7 7.4 2 2.3 0 0 1 2.9 7 7.1
idea /
remember
Refusal of
vaccinations
to the child
Yes 5 5.1 0 0 3 12.5 6 6.5 4 4.5 1 12.5 3 9.1 6 6.2 0.08
No 92 93.9 11 100 21 87.5 81 87.1 0.20 84 95.5 7 87.5 30 90.9 84 86.6
I have no 1 1 0 0 0 0 6 6.5 0 0 0 0 0 0 7 7.2
idea /
remember
Presence of
children
between the
ages of 0-18 0.048
Yes 99 26.3 12 27.3 24 36.9 97 35.5
No 278 73.7 32 72.7 41 63.1 176 64.5
The thought
of getting
COVID-19
vaccine to

This article is protected by copyright. All rights reserved

Accepted Article
child <0.001
Yes 81 81.8 4 36.4 0 0 3 3.2
If it is 1 1 6 54.5 1 4.2 0 0
free,get it
No 0 0 1 9.1 22 91.7 11 11.6
Undecided 17 17.2 0 0 1 4.2 81 85.3

Table 4. The reasons of undecision and rejection about COVID 19 vaccine

The reasons of undecision and rejection sbout COVID 19 vaccine

For themselves For their children
n % n %
Vaccines to be produced for the COVID 19 virus can cause COVID 19 55 7.2 30 4
infection.
Afraid from the side effects of vaccine. 210 27.7 90 11.9
COVID 19 infection is a biological weapon and I think that the vaccine 104 13.7 42 5.5
will serve those who produce this virus.
Dont think it can be reliable as it will be a new vaccine. 208 27.4 78 10.3
Dont think that the vaccines produced for COVID 19 virus can be 62 8.2 23 3
effective.
Don't think to have enough information about vaccines. 66 8.7 30 4

This article is protected by copyright. All rights reserved

Accepted Article
COVID 19 infection is exaggerated, it is not a risky disease, so no 11 1.4 7 0.9
vaccine is needed.
Prefering other ways of protection. 55 7.2 29 3.8
Dont not intend to be vaccinated because of having COVID 19 1 0.1 - -
infection.
Waiting for vaccination until child grows a little older. - - 13 1.7
In general, having doubts about vaccinations. - - 21 2.8
Other 24 3.2 9 1.2

Table 5. The reasons of request for COVID 19 vaccine

The reasons of request for COVID 19 vaccine

For themselves For their childeren
n % n %
COVID 19 vaccine will end the outbreak. 170 22.4 43 5.7
Vaccination will be important to protect against COVID19 disease. 287 37.8 85 11.2
Vaccination will be important not only for myself/my children but also 350 46.1 74 9.7
for protecting the health of people around me/my children.
COVID 19 vaccine will reduce the duration and severity of this disease. 279 36.8 61 8
Other 10 1.3 3 0.4

This article is protected by copyright. All rights reserved